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Abstract
The study aims to identify the Type 2 Diabetes patients who are at risk of developing diabetic Kidney Disease
(DKD). This study compares the performance of classification algorithms that are commonly used to
identify patients at risk of developing DKD when predicting for short, medium and long terms. We used
5,097 records at 36 clinics from 2005 to 2017. Syntactic minority oversampling and random undersampling
were used to create a balanced dataset. Our findings show that the performance of classification algorithms
depends on both the period and purpose of prediction, whether the prediction is to identify people who will
not develop DKD or determine at-risk patients. Undersampling as opposed to oversampling improved
performance. 19 predictors and their importance in short, medium and long terms were identified. This
study provides guidelines for an automated system to prompt type-2 diabetes patients for screening, which
offers a potential reduction of the burden placed upon the clinical settings.
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Extended Abstract
One of the major complications of Type 2 Diabetes (T2D) is diabetic kidney disease (DKD). The T2D
prevalence is increasing worldwide (World Health Organization, 2016) from 382 million in 2013 to 592
million people in 2035 (Aguiree et al., 2013). Landray et al. (2010) have reported that 25-40% of patients
with T2D develop chronic kidney disease. DKD is associated with the increased mortality among T2D
patients (Afkarian et al., 2013). While out of five stages of DKD, the identification of patients at early stages
of 1-3 is important for the treatment; typically signs and symptoms of DKD do not show up until later stages
(Ware, 2018). The rise in the number of T2D patients and the fact that T2D is the leading cause of chronic
kidney disease (Subramanian and Hirsch, 2018) make it imperative to identify T2D patients at risk of DKD
early. This enables targeted disease management in order to prevent the progression of DKD.
There are two approaches for preventing DKD progression among T2D patients. In the first approach, every
T2D patient is targeted by public health policies, which is highly costly (Jain and Mottl, 2015). In the second
approach, a subpopulation of T2D patients is predicted as “at-risk” using machine learning classification
algorithms. Machine learning techniques have the potential to recognize the complex patterns in electronic
medical records (EMR) and identify patients at risk of developing diseases (Capan et al., 2017; Ferroni et
al., 2017; Lagani et al., 2013; Uyar et al., 2015) such as DKD. Advances in the field of machine learning allow
for better predictions of target groups with the risk of DKD progression (Low et al., 2017). Prediction of
DKD offers the promise of prioritizing diagnostic and therapeutic processes in the context of overwhelming
patient demand. On an individual patient care basis, physicians are well-equipped to identify those at risk
of DKD. However, when attempting to issue proactive, appropriate notification to patients to schedule an
appointment for laboratory screening across a patient panel of thousands, the choice of good classification
algorithm is an important challenge; that is the topic of this article.
The current study aims to answer the following research questions (RQ):
RQ1: Is there any difference in performance of classification algorithms to identify patients at risk of DKD
progression when predicting for short, medium, or long-term and using random sampling, SMOTE, or
RUS?
RQ2: What are the predictors of DKD? Does the importance of each predictor change when predicting for
short, medium, or long term?

Figure 1. Methodology
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In order to answer to the above questions, the current study runs the classification algorithms used in
previous literature (Leung et al., 2013); namely partial least square regression (PLSR), classification and
regression tree (C&RT), C5.0 decision tree (C 5.0 DT), random forest (RF), naïve Bayes (NB), neural
network (NN) and support vector machine (SVM) for the linked daily generated EMRs collected from 36
general practice offices. The resampling techniques were no resampling, SMOTE, and RUS. In addition, the
analysis was conducted for 1 year, 3 years and 8 years of prediction. Our findings show that the performance
of predictive techniques to predict DKD depends on 1) the period of prediction being short, medium, or
long-term and 2) whether the purpose of prediction is to identify T2D patients at risk of developing DKD
or those that are not at risk. Figure 1 presents the methodology used in this study.
Our findings show that both discrimination and calibration performances of predictive technique are not
only related to the period of prediction (short, medium, and long-term), but also depends on the purpose
of prediction, whether the prediction is an attempt to identify T2D people who will not develop DKD or
identify T2D patients at risk of developing DKD. For instance, in the short term, NN-RUS shows better
performance as measured by AUC and MCC and MCE particularly when the prediction is looking for T2D
patients who are going to develop DKD, measured by sensitivity. However, the results show that C 5.0 DTRUS better predicts T2D patients who are not at risk of DKD, since its specificity is higher than other
predictive methods. When predicting for the medium and long terms, the choice of technique, we can
similarly observe that RF-RUS has the best performance, unless the objective is to identify T2D patients
who are not at risk of developing DKD. Although in 8-year prediction RF-SMOTE showed better MCE
compared to RF-RUS, the difference was not statistically significant and as such, it can be treated similarly
to RF-RUS. We have incorporated these results in full paper.
This is the first time in literature that the change of predictors’ importance for developing DKD among T2D
patients has been examined through different predicting periods (1, 3, and 8-year predictions).
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